Custom service

Disulfide-rich Cyclic Peptides

Build disulfide-rich cyclic scaffolds such as cyclotides with defined connectivity

Turnaround: 5–9 weeksTypical scale: 0.5 mg – 1 g modified peptideChemistry options: orthogonal Cys-protection pairing; regioselective disulfide folding; oxidative-folding screening

Disulfide-rich Cyclic Peptides supports programmes that build disulfide-rich cyclic scaffolds such as cyclotides with defined connectivity. In a typical engagement we plan the orthogonal Cys-protection pairing route first, confirm compatibility with regioselective disulfide folding, and release folded disulfide-rich cyclic peptide with connectivity data on a 5–9 weeks schedule.

Chemistry is chosen for the molecule, not from a menu. Where the payload tolerates it we keep orthogonal Cys-protection pairing as the primary option and hold regioselective disulfide folding in reserve, so that scale-up never depends on an unproven step.

Cyclotide and sunflower-trypsin-inhibitor scaffolds

Conotoxin and knottin analogs

Scaffolds requiring cell-based folding quality control

Modifications requiring radiological or BSL-3 containment

Modified peptides are released against a specification that includes site occupancy. Where a modification is labile (sulfation, glycosylation, phosphorylation), we use fragmentation data rather than mass shift alone to assign the site, and we state detection limits for any positional isomers that co-elute.

Service Highlights

  • Orthogonal Cys-protection pairing as the default route, with regioselective disulfide folding held as a proven fallback
  • Oxidative-folding screening worked into the design where the application requires it
  • Modification sites are mapped on the sequence and confirmed by MS/MS before release
  • Analytical confirmation of every intermediate before the final release
  • Modified and unmodified species are separated and quantified, not just reported
  • Folded disulfide-rich cyclic peptide with connectivity data delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Sequence & modification map

    We annotate every modification site, protection strategy and analytical target before synthesis starts.

  2. Solid-phase assembly

    The chain is built with Fmoc chemistry, inserting modified or unnatural residues at the mapped positions.

  3. Modification chemistry

    Post-synthesis steps — orthogonal Cys-protection pairing, regioselective disulfide folding — are run under conditions validated on a test cleavage.

  4. Cleavage & purification

    Global deprotection and cleavage are followed by RP-HPLC purification to the agreed purity.

  5. Analytical release

    Purity, identity and modification ratio are confirmed by HPLC, MS and MS/MS site mapping.

  6. Documentation

    Folded disulfide-rich cyclic peptide with connectivity data is released with the batch record and analytical package after QC sign-off.

Specifications & timeline

Turnaround
5–9 weeks
Typical scale
0.5 mg – 1 g modified peptide
Chemistry options
orthogonal Cys-protection pairing; regioselective disulfide folding; oxidative-folding screening
Deliverable
Folded disulfide-rich cyclic peptide with connectivity data
QC package
HPLC purity, ESI/MALDI MS, MS/MS site mapping, modification ratio
Shipping
Ambient or blue ice as stability data dictate

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.